DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

1INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 125973-56-0, Tac-101, Am 555s, Amsilarotene [inn], Am555s,tac-101, 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid

Molecular Formula

C₂₀H₂₇NO₃Si₂

Molecular Weight

385.6 g/mol

InChI Key

VVTNSTLJOVCBDL-UHFFFAOYSA-N

FDA UNII

Q1418F39MH

Amsilarotene is a retinobenzoic acid with potential antineoplastic activity. Amsilarotene inhibits retinoblastoma-gene product (RB) phosphorylation and increases the presence of 2 cyclin-dependent kinase (CDK) inhibitors, resulting in cell cycle arrest. This agent also causes a cytotoxic decline in cyclin A and thymidylate synthase expression.

1 2D Structure

Tac 101

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid

2.1.2 InChI

InChI=1S/C20H27NO3Si2/c1-25(2,3)17-11-15(12-18(13-17)26(4,5)6)19(22)21-16-9-7-14(8-10-16)20(23)24/h7-13H,1-6H3,(H,21,22)(H,23,24)

2.1.3 InChI Key

VVTNSTLJOVCBDL-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C[Si](C)(C)C1=CC(=CC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)O)[Si](C)(C)C

2.2 Other Identifiers

2.2.1 UNII

Q1418F39MH

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4-(3,5-bis(trimethylsilyl)benzamido)benzoic Acid

2. Am 555s

3. Am-555s

4. Am555s

5. Tac 101

6. Tac-101

2.3.2 Depositor-Supplied Synonyms

1. 125973-56-0

2. Tac-101

3. Am 555s

4. Amsilarotene [inn]

5. Am555s,tac-101

6. 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic Acid

7. Amsilarotene; Tac 101

8. Q1418f39mh

9. 4-[3,5-bis(trimethylsilyl) Benzamido] Benzoic Acid

10. Benzoic Acid, 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]-

11. Am-555s

12. Tac 101

13. 4-(3,5-bis(trimethylsilyl)benzamido)benzoic Acid

14. Benzoic Acid, 4-((3,5-bis(trimethylsilyl)benzoyl)amino)-

15. Unii-q1418f39mh

16. Ccris 9419

17. 4-(3,5-bis(trimethylsilyl)benzamido) Benzoic Acid

18. Amsilarotene [who-dd]

19. Chembl32994

20. Schembl1133175

21. Dtxsid90155013

22. Ex-a128

23. Bcp06502

24. Akos032947226

25. Zinc169746726

26. Ac-36797

27. Da-13333

28. Hy-14653

29. Cs-0003504

30. Ft-0769431

31. A13122

32. Q27286879

33. 5-(4-methylphenyl)furan-2-carboxylicacidmethylester

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₂₇NO₃Si₂
Molecular Weight	385.6 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	5
Exact Mass	385.15294679 g/mol
Monoisotopic Mass	385.15294679 g/mol
Topological Polar Surface Area	66.4 Å²
Heavy Atom Count	26
Formal Charge	0
Complexity	494
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1